Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Safety, Pharmacodynamics and Pharmacokinetic Characteristics of Multiple Subcutaneous Injections of LP-98 in Primary Treatment of HIV-infected Patients

NCT06560489 is registered in ClinicalTrials.gov with Shanxi Kangbao Biological Product Co., Ltd. as lead sponsor.

NCT NCT06560489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06560489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Safety, Pharmacodynamics and Pharmacokinetic Characteristics of Multiple Subcutaneous Injections of LP-98 in Primary Treatment of HIV-infected Patients
Lead sponsor
Shanxi Kangbao Biological Product Co., Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
September 2, 2024
Completion date
August 22, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv